The Kidney Commute Podcast seeks to enhance the work of the interprofessional kidney care team by providing connection through education and serving as an innovative opportunity to fulfill CE requirements.
All content for Kidney Commute is the property of kidneycommute and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The Kidney Commute Podcast seeks to enhance the work of the interprofessional kidney care team by providing connection through education and serving as an innovative opportunity to fulfill CE requirements.
In this episode of the Kidney Commute podcast, panelists delve into the role of glucagon-like peptide-1 (GLP-1) receptor agonists in chronic kidney disease. The discussion explores the mechanisms of GLP-1 receptor agonists, their benefits in managing both kidney disease and related comorbidities like diabetes and cardiovascular disease, and the latest evidence supporting their use. Panelists also address practical challenges faced by both patients and providers.
Click here to claim CE Credit.
Kidney Commute
The Kidney Commute Podcast seeks to enhance the work of the interprofessional kidney care team by providing connection through education and serving as an innovative opportunity to fulfill CE requirements.
